Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
122 participants
INTERVENTIONAL
2011-11-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece
NCT01957553
Safety and Performance Investigation of a New 1-piece Ostomy Product Compared to Standard of Care 1-piece in Subjects With Ileostomy
NCT01994863
Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura
NCT01799239
Safety and Performance of New 1-piece Ostomy Product
NCT01800916
Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care
NCT01517178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Standard Care, then SenSura Mio
Subjects first test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima) and after cross-over SenSura Mio
SenSura Mio
Ostomy product - 1 piece closed bag
Standard Care
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
First SenSura Mio, then Standard Care
Subjects first test SenSura Mio and after cross-over Standard Care(Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)
SenSura Mio
Ostomy product - 1 piece closed bag
Standard Care
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SenSura Mio
Ostomy product - 1 piece closed bag
Standard Care
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be at least 18 years of age and have full legal capacity.
3. Have experienced leakage under the base plate at least once a week over the last two weeks.
4. Be able to handle the bags themselves or with help from caregiver (e.g. spouse).
5. Have a colostomy with a diameter between 20 and 45 mm.
6. Have had their ostomy for at least three months.
7. Currently use a 1-piece flat product with closed bag.
8. Use minimum 1 product per day.
9. Be suitable for participation in the investigation and for using a standard adhesive, flat base plate (evaluated by investigator).
Exclusion Criteria
2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
4. Are pregnant or breastfeeding.
5. Participating in other interventional clinical investigations or have previously participated in this investigation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenche Sundberg, stoma nurse
Role: PRINCIPAL_INVESTIGATOR
Diakonhjemmet Sykhus, Oslo
Merete Bjørke, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
St. Olavs Hopsital
Vigids Dagsland, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
Haugesund Sykhus
Randi Melum, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
St. Olavs Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Publicare
Cologne, Køln, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP219
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.